PCI BIOTECH HOLDING ASA: årsregnskap 2021 vs 2020
Slipped into loss, cash halved-plus
approved 2022-05-25; registry 2022-06-14; journal 2022 420791
Summary
What changed
Comparing Årsregnskap 2021 with 2020 for PCI BIOTECH HOLDING ASA. Revenue 0 NOK → 6.27m NOK. Net result +429 NOK → -154.91m NOK. Equity 686.5k NOK → 544.57m NOK.
On the constructive side: revenue rose; equity strengthened; owners injected capital. Pressures included: operating result weakened; fell into a net loss; cash fell.
Also worth watching: sharp cash drawdown; book investments changed. All figures are taken from the published annual accounts for PCI BIOTECH HOLDING ASA.
At a glance
Scorecard
What improved
-
↑
Revenue rose
Operating income / revenue moved from 0 NOK to 6.27m NOK. Calculated
-
↑
Equity strengthened
Book equity 686.5k NOK → 544.57m NOK (equity ratio 99.8% → 99.8%). Calculated
-
↑
Owners injected capital
Paid-in equity rose 491.8k NOK → 504.8k NOK (+12.9k NOK). Reported fact
What deteriorated
-
↓
Operating result weakened
Operating result -4.66m NOK → -4.97m NOK. Calculated
-
↓
Fell into a net loss
Net result flipped from 429 NOK profit to a loss of 154.91m NOK. Calculated
-
↓
Cash fell
Bank deposits 68.47m NOK → 26.48m NOK (-61.3% YoY). Calculated
Things to notice
-
·
Sharp cash drawdown
Cash fell by more than 60% YoY (68.47m NOK → 26.48m NOK). Check whether funds moved to group receivables, investments, or operating burn. Interpretation
-
·
Book investments changed
Investment / intangible book value 600.1k NOK → 504.19m NOK. Reported fact